Skip to main content

Banyai William's Form 4 filing

Twist Bioscience Corp (TWST) · filed Dec 17, 2021

Accession no.
0001214659-21-013350
Filed
Dec 17, 2021
Trade date
Dec 15, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market sales total $2.13M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Banyai WilliamCIK 0001753670Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 15, 2021Common StockSSaleDisposed−3,700$83.50−$308,950281,728Direct
Dec 15, 2021Common StockSSaleDisposed−11,769$84.36−$992,832.84269,959Direct
Dec 15, 2021Common StockSSaleDisposed−4,370$85.29−$372,717.3265,589Direct
Dec 15, 2021Common StockSSaleDisposed−1,206$86.30−$104,077.8264,383Direct
Dec 15, 2021Common StockSSaleDisposed−506$87.57−$44,310.42263,877Direct
Dec 15, 2021Common StockSSaleDisposed−2,439$88.88−$216,778.32261,438Direct
Dec 15, 2021Common StockSSaleDisposed−1,010$89.50−$90,395260,428Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Senior Vice President of Advanced Development and General Manager of Data Storage

Read the full filing on SEC EDGAR (opens in a new tab)